MARSHALL WACE, LLP: EMR position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MARSHALL WACE, LLP on EMR, newest first. How the timeline and the estimate are built.
MARSHALL WACE, LLP held 279,107 EMR shares at 2026-06-30 per its 13F-HR filed 2026-08-13.
the latest 13F is the newest step
- period ended2026-06-3013F 279,107 sharesChange vs previous 13F -68,296 shares
0.03% of the 13F portfolio, value $39,954,168.
13F-HR 0001318757-26-000010 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 347,403 sharesChange vs previous 13F +347,403 shares
0.05% of the 13F portfolio, value $45,516,741.
13F-HR 0001318757-26-000005 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 0 sharesChange vs previous 13F -2,658 shares
13F-HR 0001318757-26-000003 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 2,658 sharesChange vs previous 13F -1,284,097 shares
<0.01% of the 13F portfolio, value $348,676.
13F-HR 0001318757-25-000046 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 1,286,755 sharesChange vs previous 13F +548,795 shares
0.2% of the 13F portfolio, value $171,563,044.
13F-HR 0001318757-25-000034 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 737,960 sharesChange vs previous 13F +723,120 shares
0.11% of the 13F portfolio, value $80,909,935.
13F-HR 0001318757-25-000023 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 14,840 sharesChange vs previous 13F -30,508 shares
<0.01% of the 13F portfolio, value $1,839,121.
13F-HR 0002048047-25-000005 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 45,348 sharesChange vs previous 13F not available
0.01% of the 13F portfolio, value $4,959,711.
13F-HR 0001318757-24-000018 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).